Mon, 28 Jul 2014 | DIVISION SALE
Biophysical technology firm Malvern Instruments has expanded its service portfolio with the purchase of the Archimedes particle characterisation system from US-based Affinity Biosensors, and a separate deal to buy MicroCal.
The deals will boost Malvern’s portfolio of analytical services for the biopharmaceutical sector. Malvern Instruments and Affinity Biosensors had been working together for two years prior to the deal, which enabled Malvern to use the technique of resonant mass measurement.
Archimedes is now fully owned by Malvern, along with its product designs, IP and a licence to the underlying MIT patent for the technology within other fields.
Paul Walker, Malvern’s managing director, commented: “Archimedes sits alongside Zetasizer and NanoSight nanoparticle tracking systems, delivering a range of complementary solutions for quantifying early aggregation in bioformulations.”
While the deal to acquire GE Healthcare Life Sciences’ MicroCal business was announced last month and had been subject to regulatory approval.
MicroCal microcalorimeters are now being sold and serviced by Malvern Instruments.
Mr Walker said: ‘MicroCal microcalorimeters are an exciting and important new addition to Malvern’s portfolio that will significantly extend our ability to serve customers working in pharmaceutical and biopharmaceutical discovery, development and formulation.”
_____________________________________________________________________
Related information:
Medical businesses for sale
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.